The ZZ domain as a new epigenetic reader and a degradation signal sensor

References

• Afroz T, Skrisovska L, Belloc E, Guillen-Boixet J, Mendez R, Allain FH. 2014. A fly trap mechanism provides sequence-specific RNA recognition by CPEB proteins. Genes Dev. 28:1498–1514.
   PubMed Web of Science ®Google Scholar
• Andrews FH, Strahl BD, Kutateladze TG. 2016. Insights into newly discovered marks and readers of epigenetic information. Nat Chem Biol. 12:662–668.
   PubMed Web of Science ®Google Scholar
• Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC, Kouzarides T. 2001. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature. 410:120–124.
   PubMed Web of Science ®Google Scholar
• Bedford DC, Kasper LH, Fukuyama T, Brindle PK. 2010. Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics. 5:9–15.
   PubMed Web of Science ®Google Scholar
• Bian C, Xu C, Ruan J, Lee KK, Burke TL, Tempel W, Barsyte D, Li J, Wu M, Zhou BO, et al. 2011. Sgf29 binds histone H3K4me2/3 and is required for SAGA complex recruitment and histone H3 acetylation [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.]. EMBO J. 30:2829–2842.
   PubMed Web of Science ®Google Scholar
• Cha-Molstad H, Lee SH, Kim JG, Sung KW, Hwang J, Shim SM, Ganipisetti S, McGuire T, Mook-Jung I, Ciechanover A, et al. 2018. Regulation of autophagic proteolysis by the N-recognin SQSTM1/p62 of the N-end rule pathway. Autophagy. 1:3.
   Google Scholar
• Cha-Molstad H, Sung KS, Hwang J, Kim KA, Yu JE, Yoo YD, Jang JM, Han DH, Molstad M, Kim JG, et al. 2015. Amino-terminal arginylation targets endoplasmic reticulum chaperone BiP for autophagy through p62 binding. Nat Cell Biol. 17:917–929.
   PubMed Web of Science ®Google Scholar
• Cha-Molstad H, Yu JE, Feng Z, Lee SH, Kim JG, Yang P, Han B, Sung KW, Yoo YD, Hwang J, et al. 2017. p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis. Nat Commun. 8:102.
   PubMed Web of Science ®Google Scholar
• Conery AR, Centore RC, Neiss A, Keller PJ, Joshi S, Spillane KL, Sandy P, Hatton C, Pardo E, Zawadzke L, et al. 2016. Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. eLife. 5:e10483.
   PubMed Web of Science ®Google Scholar
• Constantin B. 2014. Dystrophin complex functions as a scaffold for signalling proteins. Biochim Biophys Acta. 1838:635–642.
   PubMed Web of Science ®Google Scholar
• Dancy BM, Cole PA. 2015. Protein lysine acetylation by p300/CBP. Chem Rev. 115:2419–2452.
   PubMed Web of Science ®Google Scholar
• Danielsen JR, Povlsen LK, Villumsen BH, Streicher W, Nilsson J, Wikstrom M, Bekker-Jensen S, Mailand N. 2012. DNA damage-inducible SUMOylation of HERC2 promotes RNF8 binding via a novel SUMO-binding Zinc finger. J Cell Biol. 197:179–187.
   PubMed Web of Science ®Google Scholar
• Debes JD, Sebo TJ, Lohse CM, Murphy LM, Haugen DA, Tindall DJ. 2003. p300 in prostate cancer proliferation and progression. Cancer Res. 63:7638–7640.
   PubMed Web of Science ®Google Scholar
• Delvecchio M, Gaucher J, Aguilar-Gurrieri C, Ortega E, Panne D. 2013. Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation. Nat Struct Mol Biol. 20:1040–1046.
   PubMed Web of Science ®Google Scholar
• Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM. 1999. Structure and ligand of a histone acetyltransferase bromodomain. Nature. 399:491–496.
   PubMed Web of Science ®Google Scholar
• Duran A, Hernandez ED, Reina-Campos M, Castilla EA, Subramaniam S, Raghunandan S, Roberts LR, Kisseleva T, Karin M, Diaz-Meco MT, et al. 2016. p62/SQSTM1 by binding to vitamin D receptor inhibits hepatic stellate cell activity, fibrosis, and liver cancer. Cancer Cell. 30:595–609.
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Picaud S, Mangos M, Keates T, Lambert JP, Barsyte-Lovejoy D, Felletar I, Volkmer R, Muller S, Pawson T, et al. 2012. Histone recognition and large-scale structural analysis of the human bromodomain family [Research Support, Non-U.S. Gov't]. Cell. 149:214–231.
   PubMed Web of Science ®Google Scholar
• Gao Y, Geng J, Hong X, Qi J, Teng Y, Yang Y, Qu D, Chen G. 2014. Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. Int J Clin Exp Pathol. 7:760–767.
   PubMedGoogle Scholar
• Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin SF, Daigo Y, Russell P, Wilson A, Sowter HM, et al. 2000. Mutations truncating the EP300 acetylase in human cancers. Nat Genet. 24:300–303.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Taylor A, Chin M, Huang HR, Conery AR, Mertz JA, Salmeron A, Dakle PJ, Mele D, Cote A, et al. 2016. Regulatory T cell modulation by CBP/EP300 bromodomain inhibition. J Biol Chem. 291:13014–13027.
   PubMed Web of Science ®Google Scholar
• Giotopoulos G, Chan WI, Horton SJ, Ruau D, Gallipoli P, Fowler A, Crawley C, Papaemmanuil E, Campbell PJ, Gottgens B, et al. 2016. The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia. Oncogene. 35:279–289.
   PubMed Web of Science ®Google Scholar
• Goodman RH, Smolik S. 2000. CBP/p300 in cell growth, transformation, and development . Genes Dev. 14:1553–1577.
   PubMed Web of Science ®Google Scholar
• Guelman S, Suganuma T, Florens L, Swanson SK, Kiesecker CL, Kusch T, Anderson S, Yates JR, Washburn MP, Abmayr SM, et al. 2006. Host cell factor and an uncharacterized SANT domain protein are stable components of ATAC, a novel dAda2A/dGcn5-containing histone acetyltransferase complex in Drosophila. Mol Cell Biol. 26:871–882.
   PubMed Web of Science ®Google Scholar
• Haery L, Lugo-Pico JG, Henry RA, Andrews AJ, Gilmore TD. 2014. Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth. Mol Cancer. 13:29.
   PubMed Web of Science ®Google Scholar
• Hammitzsch A, Tallant C, Fedorov O, O’Mahony A, Brennan PE, Hay DA, Martinez FO, Al-Mossawi MH, de Wit J, Vecellio M, et al. 2015. CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. Proc Natl Acad Sci USA. 112:10768–10773.
   PubMed Web of Science ®Google Scholar
• Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA, Young RA. 2013. Super-enhancers in the control of cell identity and disease. Cell. 155:934–947.
   PubMed Web of Science ®Google Scholar
• Hou X, Li Y, Luo RZ, Fu JH, He JH, Zhang LJ, Yang HX. 2012. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers. Eur J Surg Oncol. 38:523–530.
   PubMed Web of Science ®Google Scholar
• Huang H, Lin S, Garcia BA, Zhao Y. 2015. Quantitative proteomic analysis of histone modifications. Chem Rev. 115:2376–2418.
   PubMed Web of Science ®Google Scholar
• Hudson BP, Martinez-Yamout MA, Dyson HJ, Wright PE. 2000. Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain. J Mol Biol. 304:355–370.
   PubMed Web of Science ®Google Scholar
• Ionov Y, Matsui S, Cowell JK. 2004. A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability. Proc Natl Acad Sci USA. 101:1273–1278.
   PubMed Web of Science ®Google Scholar
• Itoh M, Kim CH, Palardy G, Oda T, Jiang YJ, Maust D, Yeo SY, Lorick K, Wright GJ, Ariza-McNaughton L, et al. 2003. Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev Cell. 4:67–82.
   PubMed Web of Science ®Google Scholar
• Jacobs SA, Khorasanizadeh S. 2002. Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail. Science. 295(5562):2080–2083.
   PubMed Web of Science ®Google Scholar
• Jenuwein T, Allis CD. 2001. Translating the histone code. Science. 293(5532):1074–1080.
   PubMed Web of Science ®Google Scholar
• Jin Q, Yu LR, Wang L, Zhang Z, Kasper LH, Lee JE, Wang C, Brindle PK, Dent SY, Ge K. 2011. Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J. 30:249–262.
   PubMed Web of Science ®Google Scholar
• Joazeiro CA, Weissman AM. 2000. RING finger proteins: mediators of ubiquitin ligase activity. Cell. 102:549–552.
   PubMed Web of Science ®Google Scholar
• Kirkin V, Lamark T, Sou YS, Bjorkoy G, Nunn JL, Bruun JA, Shvets E, McEwan DG, Clausen TH, Wild P, et al. 2009. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell. 33:505–516.
   PubMed Web of Science ®Google Scholar
• Kouzarides T. 2007. Chromatin modifications and their function. Cell. 128:693–705.
   PubMed Web of Science ®Google Scholar
• Kutateladze TG. 2006. Phosphatidylinositol 3-phosphate recognition and membrane docking by the FYVE domain. Biochim Biophys Acta. 1761:868–877.
   PubMed Web of Science ®Google Scholar
• Kutateladze TG. 2011. SnapShot: histone readers. Cell. 146:842–842.
   PubMed Web of Science ®Google Scholar
• Kwon DH, Park OH, Kim L, Jung YO, Park Y, Jeong H, Hyun J, Kim YK, Song HK. 2018. Insights into degradation mechanism of N-end rule substrates by p62/SQSTM1 autophagy adapter. Nat Commun. 9:3291.
   PubMed Web of Science ®Google Scholar
• Lasko LM, Jakob CG, Edalji RP, Qiu W, Montgomery D, Digiammarino EL, Hansen TM, Risi RM, Frey R, Manaves V, et al. 2017. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours. Nature. 550:128–132.
   PubMed Web of Science ®Google Scholar
• Lee JH, Yang B, Lindahl AJ, Damaschke N, Boersma MD, Huang W, Corey E, Jarrard DF, Denu JM. 2017. Identifying dysregulated epigenetic enzyme activity in castrate-resistant prostate cancer development. ACS Chem Biol. 12:2804–2814.
   PubMed Web of Science ®Google Scholar
• Li H, Ilin S, Wang W, Duncan EM, Wysocka J, Allis CD, Patel DJ. 2006. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature. 442:91–95.
   PubMed Web of Science ®Google Scholar
• Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA. 2013. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 153:320–334.
   PubMed Web of Science ®Google Scholar
• Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, et al. 2009. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 137:1062–1075.
   PubMed Web of Science ®Google Scholar
• McMillan BJ, Schnute B, Ohlenhard N, Zimmerman B, Miles L, Beglova N, Klein T, Blacklow SC. 2015. A tail of two sites: a bipartite mechanism for recognition of notch ligands by mind bomb E3 ligases. Mol Cell. 57:912–924.
   PubMed Web of Science ®Google Scholar
• Mi W, Guan H, Lyu J, Zhao D, Xi Y, Jiang S, Andrews FH, Wang X, Gagea M, Wen H, et al. 2017. YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer. Nat Commun. 8:1088.
   PubMed Web of Science ®Google Scholar
• Mi W, Zhang Y, Lyu J, Wang X, Tong Q, Peng D, Xue Y, Tencer AH, Wen H, Li W, et al. 2018. The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation. Nat Commun. 9:3759.
   PubMed Web of Science ®Google Scholar
• Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, et al. 2011. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 476:298–303.
   PubMed Web of Science ®Google Scholar
• Moscat J, Diaz-Meco MT. 2009. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell. 137:1001–1004.
   PubMed Web of Science ®Google Scholar
• Musselman CA, Kutateladze TG. 2011. Handpicking epigenetic marks with PHD fingers [Research Support, N.I.H., Extramural Review]. Nucleic Acids Res. 39:9061–9071.
   PubMed Web of Science ®Google Scholar
• Musselman CA, Lalonde ME, Cote J, Kutateladze TG. 2012. Perceiving the epigenetic landscape through histone readers. Nat Struct Mol Biol. 19:1218–1227.
   PubMed Web of Science ®Google Scholar
• Niederriter AR, Varshney A, Parker SC, Martin DM. 2015. Super enhancers in cancers, complex disease, and developmental disorders. Genes. 6:1183–1200.
   PubMed Web of Science ®Google Scholar
• Nielsen PR, Nietlispach D, Mott HR, Callaghan J, Bannister A, Kouzarides T, Murzin AG, Murzina NV, Laue ED. 2002. Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9. Nature. 416:103–107.
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, et al. 2011. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 471:189–195.
   PubMed Web of Science ®Google Scholar
• Peña PV, Davrazou F, Shi X, Walter KL, Verkhusha VV, Gozani O, Zhao R, Kutateladze TG. 2006. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature. 442:100–103.
   PubMed Web of Science ®Google Scholar
• Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RC, Masuno M, Tommerup N, van Ommen GJ, Goodman RH, Peters DJ. 1995. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature. 376:348–351.
   PubMed Web of Science ®Google Scholar
• Ponting CP, Blake DJ, Davies KE, Kendrick-Jones J, Winder SJ. 1996. ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. Trends Biochem Sci. 21:11–13.
   PubMed Web of Science ®Google Scholar
• Ramesh Babu J, Lamar Seibenhener M, Peng J, Strom AL, Kemppainen R, Cox N, Zhu H, Wooten MC, Diaz-Meco MT, Moscat J, et al. 2008. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem. 106:107–120.
   PubMed Web of Science ®Google Scholar
• Richter JD. 2007. CPEB: a life in translation. Trends Biochem Sci. 32:279–285.
   PubMed Web of Science ®Google Scholar
• Riss A, Scheer E, Joint M, Trowitzsch S, Berger I, Tora L. 2015. Subunits of ADA-two-A-containing (ATAC) or Spt-Ada-Gcn5-acetyltrasferase (SAGA) coactivator complexes enhance the acetyltransferase activity of GCN5. J Biol Chem. 290:28997–29009.
   PubMed Web of Science ®Google Scholar
• Shi X, Hong T, Walter KL, Ewalt M, Michishita E, Hung T, Carney D, Pena P, Lan F, Kaadige MR, et al. 2006. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature. 442:96–99.
   PubMed Web of Science ®Google Scholar
• Solomon BD, Bodian DL, Khromykh A, Mora GG, Lanpher BC, Iyer RK, Baveja R, Vockley JG, Niederhuber JE. 2015. Expanding the phenotypic spectrum in EP300-related Rubinstein-Taybi syndrome. Am J Med Genet. 167:1111–1116.
   Web of Science ®Google Scholar
• Spedale G, Timmers HT, Pijnappel WW. 2012. ATAC-king the complexity of SAGA during evolution. Genes Dev. 26:527–541.
   PubMed Web of Science ®Google Scholar
• Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature. 403:41–45.
   PubMed Web of Science ®Google Scholar
• Suganuma T, Gutierrez JL, Li B, Florens L, Swanson SK, Washburn MP, Abmayr SM, Workman JL. 2008. ATAC is a double histone acetyltransferase complex that stimulates nucleosome sliding. Nat Struct Mol Biol. 15:364–372.
   PubMed Web of Science ®Google Scholar
• Sun J, Paduch M, Kim SA, Kramer RM, Barrios AF, Lu V, Luke J, Usatyuk S, Kossiakoff AA, Tan S. 2018. Structural basis for activation of SAGA histone acetyltransferase Gcn5 by partner subunit Ada2. Proc Natl Acad Sci USA. 115:10010–10015.
   PubMed Web of Science ®Google Scholar
• Tang Z, Chen WY, Shimada M, Nguyen UT, Kim J, Sun XJ, Sengoku T, McGinty RK, Fernandez JP, Muir TW, et al. 2013. SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53. Cell. 154:297–310.
   PubMed Web of Science ®Google Scholar
• Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. 2007. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol. 14:1025–1040.
   PubMed Web of Science ®Google Scholar
• Todoric J, Antonucci L, Di Caro G, Li N, Wu X, Lytle NK, Dhar D, Banerjee S, Fagman JB, Browne CD, et al. 2017. Stress-activated NRF2-MDM2 cascade controls neoplastic progression in pancreas. Cancer Cell. 32:824–839.
   PubMed Web of Science ®Google Scholar
• Vermeulen M, Eberl HC, Matarese F, Marks H, Denissov S, Butter F, Lee KK, Olsen JV, Hyman AA, Stunnenberg HG, et al. 2010. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers [Research Support, Non-U.S. Gov't]. Cell. 142:967–980.
   PubMed Web of Science ®Google Scholar
• Wang L, Dent SY. 2014. Functions of SAGA in development and disease. Epigenomics. 6:329–339.
   PubMed Web of Science ®Google Scholar
• Wang YL, Faiola F, Xu M, Pan S, Martinez E. 2008. Human ATAC Is a GCN5/PCAF-containing acetylase complex with a novel NC2-like histone fold module that interacts with the TATA-binding protein. J Biol Chem. 283:33808–33815.
   PubMed Web of Science ®Google Scholar
• Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA. 2013. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 153:307–319.
   PubMed Web of Science ®Google Scholar
• Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J, Kauer M, Tackett AJ, Chait BT, Badenhorst P, et al. 2006. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature. 442:86–90.
   PubMed Web of Science ®Google Scholar
• Yokomizo C, Yamaguchi K, Itoh Y, Nishimura T, Umemura A, Minami M, Yasui K, Mitsuyoshi H, Fujii H, Tochiki N, et al. 2011. High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells. Cancer Lett. 310:140–147.
   PubMed Web of Science ®Google Scholar
• Zeng L, Zhang Q, Gerona-Navarro G, Moshkina N, Zhou MM. 2008. Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300. Structure. 16:643–652.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Mun SR, Linares JF, Ahn J, Towers CG, Ji CH, Fitzwalter BE, Holden MR, Mi W, Shi X, et al. 2018. ZZ-dependent regulation of p62/SQSTM1 in autophagy. Nat Commun. 9:4373.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xue Y, Shi J, Ahn J, Mi W, Ali M, Wang X, Klein BJ, Wen H, Li W, et al. 2018. The ZZ domain of p300 mediates specificity of the adjacent HAT domain for histone H3. Nat Struct Mol Biol. 25:841–849.
   PubMed Web of Science ®Google Scholar